We are live on ! Find out more
COGT icon

Cogent Biosciences
COGT

73 hedge funds and large institutions have $299M invested in Cogent Biosciences in 2021 Q3 according to their latest regulatory filings, with 14 funds opening new positions, 18 increasing their positions, 19 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

56% more first-time investments, than exits

New positions opened: 14 | Existing positions closed: 9

25% more funds holding in top 10

Funds holding in top 10: 4 → 5 (+1)

6% more funds holding

Funds holding: 69 → 73 (+4)

5% more capital invested

Capital invested by funds: $284M → $299M (+$15.4M)

1.06% more ownership

Funds ownership: 94.74% → 95.8% (+1.1%)

5% less repeat investments, than reductions

Existing positions increased: 18 | Existing positions reduced: 19

Holders
73
Holders Change
+4
Holders Change %
+5.8%
% of All Funds
1.28%
Holding in Top 10
5
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+25%
% of All Funds
0.09%
New
14
Increased
18
Reduced
19
Closed
9
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
VC
Vivo Capital
California
+$10.9M
2
CC
Commodore Capital
New York
+$4.18M
3
SCM
Silverarc Capital Management
Massachusetts
+$3.68M
4
MWNA
Marshall Wace North America
New York
+$2.51M
5
PCH
Polar Capital Holdings
United Kingdom
+$1.75M

Top Sellers

1
HA
HHLR Advisors
Cayman Islands
-$8.11M
2
Invesco
Invesco
Georgia
-$5.5M
3
TCM
Tekla Capital Management
Massachusetts
-$4.36M
4
LGM
Logos Global Management
California
-$3.8M
5
Point72 Asset Management
Point72 Asset Management
Connecticut
-$3.66M
Name Holding Trade Value Shares
Change 		Change in
Stake
MWNA
26
Marshall Wace North America
New York
$2.75M +$2.51M +327,332 New
SSA
27
Schonfeld Strategic Advisors
New York
$2.29M -$11.5K -1,500 -0.5%
Citigroup
28
Citigroup
New York
$2.14M +$1.66K +216 +0.1%
DCM
29
DAFNA Capital Management
California
$1.88M – – –
JP Morgan Chase
30
JP Morgan Chase
New York
$1.63M +$185K +24,104 +14%
Goldman Sachs
31
Goldman Sachs
New York
$1.26M +$1.15M +149,693 New
Bank of Montreal
32
Bank of Montreal
Ontario, Canada
$1.16M +$1.01M +131,757 New
N
33
Nuveen
North Carolina
$1.13M -$29K -3,785 -3%
AA
34
AlphaCentric Advisors
Puerto Rico
$1.13M +$91.8K +11,975 +10%
MCM
35
Moore Capital Management
New York
$995K -$27K -3,519 -3%
Charles Schwab
36
Charles Schwab
California
$790K -$460 -60 -0.1%
Wells Fargo
37
Wells Fargo
California
$679K +$618K +80,680 +8,068,000%
Franklin Resources
38
Franklin Resources
California
$458K +$418K +54,500 New
V
39
Veritable
Delaware
$419K – – –
Bank of America
40
Bank of America
North Carolina
$370K +$203K +26,523 +151%
BCM
41
Bridgeway Capital Management
Texas
$334K – – –
RhumbLine Advisers
42
RhumbLine Advisers
Massachusetts
$333K +$10.1K +1,315 +3%
Qube Research & Technologies (QRT)
43
Qube Research & Technologies (QRT)
United Kingdom
$321K -$133K -17,374 -31%
IC
44
Ikarian Capital
Texas
$258K -$84.6K -11,035 -26%
New York State Common Retirement Fund
45
New York State Common Retirement Fund
New York
$215K -$47.6K -6,215 -20%
VEA
46
Virtus ETF Advisers
New York
$196K -$9.34K -1,219 -5%
Manulife (Manufacturers Life Insurance)
47
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$182K -$11.9K -1,557 -7%
Deutsche Bank
48
Deutsche Bank
Germany
$180K -$5.26K -687 -3%
AIG
49
American International Group
New York
$171K -$3.7K -483 -2%
California State Teachers Retirement System (CalSTRS)
50
California State Teachers Retirement System (CalSTRS)
California
$169K -$239K -31,250 -61%
1
2
3 4

COGT Hedge Fund Activity: Q3 2021 in Review

73 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in Cogent Biosciences (COGT) for Q3 2021, worth a combined $299M — up 5.4% from $284M a quarter earlier.

Buyers outnumbered sellers: 14 funds opened new COGT positions and 9 closed out — a net gain of 5 holders — while 18 added to existing stakes and 19 trimmed.

The largest buyer was Vivo Capital, opening a new position worth an estimated $10.9M. The largest seller was HHLR Advisors, exiting entirely with an estimated $8.11M sold.

  • 73 institutional investors held Cogent Biosciences (COGT) as of Q3 2021, up from 69 in Q2 2021.
  • Funds reported $299M of Cogent Biosciences stock for Q3 2021, up 5.4% quarter-over-quarter.
  • 14 funds opened new Cogent Biosciences positions in Q3 2021 and 9 closed out, a net change of +5 holders.
  • The largest Cogent Biosciences buyer in Q3 2021 was Vivo Capital, an estimated $10.9M added.
  • The largest Cogent Biosciences seller in Q3 2021 was HHLR Advisors, an estimated $8.11M sold.

Based on aggregated 13F filings for Q3 2021.